These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36229047)

  • 1. In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes.
    Chanderraj R; Baker JM; Kay SG; Brown CA; Hinkle KJ; Fergle DJ; McDonald RA; Falkowski NR; Metcalf JD; Kaye KS; Woods RJ; Prescott HC; Sjoding MW; Dickson RP
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36229047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
    Pugh R; Grant C; Cooke RP; Dempsey G
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.
    Shi Z; Xie H; Wang P; Zhang Q; Wu Y; Chen E; Ng L; Worthington HV; Needleman I; Furness S
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008367. PubMed ID: 23939759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trauma and Antimicrobial Resistance Are Independent Predictors of Inadequate Empirical Antimicrobial Treatment of Ventilator-Associated Pneumonia in Critically Ill Patients.
    Jovanovic B; Djuric O; Hadzibegovic A; Jovanovic S; Stanisavljevic J; Milenkovic M; Rajkovic M; Ratkovic S; Markovic-Denic L
    Surg Infect (Larchmt); 2021 Sep; 22(7):730-737. PubMed ID: 33439780
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Achromobacter Ventilator-Associated Pneumonia in Critically Ill Trauma Patients.
    Wood GC; Jonap BL; Maish GO; Magnotti LJ; Swanson JM; Boucher BA; Croce MA; Fabian TC
    Ann Pharmacother; 2018 Feb; 52(2):120-125. PubMed ID: 28906137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
    Pugh R; Grant C; Cooke RP; Dempsey G
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
    Ghannam DE; Rodriguez GH; Raad II; Safdar A
    Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):253-9. PubMed ID: 18752007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between empiric antimicrobial therapy and the risk of clinical failure in critically ill patients with aspiration pneumonia.
    Brumit JC; Cluck DB; Brown TP; Tharp JL
    J Clin Pharm Ther; 2022 Nov; 47(11):1820-1825. PubMed ID: 36096493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit.
    Palmer LB; Smaldone GC; Chen JJ; Baram D; Duan T; Monteforte M; Varela M; Tempone AK; O'Riordan T; Daroowalla F; Richman P
    Crit Care Med; 2008 Jul; 36(7):2008-13. PubMed ID: 18552684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance.
    Medell M; Hart M; Duquesne A; Espinosa F; Valdés R
    MEDICC Rev; 2013 Apr; 15(2):26-9. PubMed ID: 23686252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia.
    Fowler RA; Flavin KE; Barr J; Weinacker AB; Parsonnet J; Gould MK
    Chest; 2003 Mar; 123(3):835-44. PubMed ID: 12628886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Gram Stain-Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia: The GRACE-VAP Randomized Clinical Trial.
    Yoshimura J; Yamakawa K; Ohta Y; Nakamura K; Hashimoto H; Kawada M; Takahashi H; Yamagiwa T; Kodate A; Miyamoto K; Fujimi S; Morimoto T
    JAMA Netw Open; 2022 Apr; 5(4):e226136. PubMed ID: 35394515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
    Johnstone J; Meade M; Lauzier F; Marshall J; Duan E; Dionne J; Arabi YM; Heels-Ansdell D; Thabane L; Lamarche D; Surette M; Zytaruk N; Mehta S; Dodek P; McIntyre L; English S; Rochwerg B; Karachi T; Henderson W; Wood G; Ovakim D; Herridge M; Granton J; Wilcox ME; Goffi A; Stelfox HT; Niven D; Muscedere J; Lamontagne F; D'Aragon F; St-Arnaud C; Ball I; Nagpal D; Girard M; Aslanian P; Charbonney E; Williamson D; Sligl W; Friedrich J; Adhikari NK; Marquis F; Archambault P; Khwaja K; Kristof A; Kutsogiannis J; Zarychanski R; Paunovic B; Reeve B; Lellouche F; Hosek P; Tsang J; Binnie A; Trop S; Loubani O; Hall R; Cirone R; Reynolds S; Lysecki P; Golan E; Cartin-Ceba R; Taylor R; Cook D;
    JAMA; 2021 Sep; 326(11):1024-1033. PubMed ID: 34546300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria.
    Choe J; Sohn YM; Jeong SH; Park HJ; Na SJ; Huh K; Suh GY; Jeon K
    Ther Adv Respir Dis; 2019; 13():1753466619885529. PubMed ID: 31680646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial.
    Yoshimura J; Yamakawa K; Kinoshita T; Ohta Y; Morimoto T
    Trials; 2018 Nov; 19(1):614. PubMed ID: 30409160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
    Hamilton LA; Christopher Wood G; Magnotti LJ; Croce MA; Martin JB; Swanson JM; Boucher BA; Fabian TC
    J Trauma Acute Care Surg; 2012 Jun; 72(6):1478-83. PubMed ID: 22695410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.